The Chromosomal Instability Pathway in Colon Cancer

被引:712
作者
Pino, Maria S. [1 ]
Chung, Daniel C. [1 ]
机构
[1] Harvard Univ, Gastrointestinal Unit, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
关键词
Genomic Instability; Chromosomal Instability; Colorectal Cancer; ABERRANT CRYPT FOCI; KIRSTEN RAS MUTATIONS; COLORECTAL-CANCER; ADENOMATOUS-POLYPOSIS; BETA-CATENIN; STEM-CELLS; TELOMERASE ACTIVITY; K-RAS; MICROSATELLITE INSTABILITY; GENOMIC INSTABILITY;
D O I
10.1053/j.gastro.2009.12.065
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
The acquisition of genomic instability is a crucial feature in tumor development and there are at least 3 distinct pathways in colorectal cancer pathogenesis: the chromosomal instability (CIN), microsatellite instability, and CpG island methylator phenotype pathways. Most cases of colorectal cancer arise through the CIN pathway, which is characterized by widespread imbalances in chromosome number (aneuploidy) and loss of heterozygosity. It can result from defects in chromosomal segregation, telomere stability, and the DNA damage response, although the full complement of genes underlying CIN remains incompletely described. Coupled with the karyotypic abnormalities observed in CIN tumors are the accumulation of a characteristic set of mutations in specific tumor suppressor genes and oncogenes that activate pathways critical for colorectal cancer initiation and progression. Whether CIN creates the appropriate milieu for the accumulation of these mutations or vice versa remains a provocative and unanswered question. The goal of this review is to provide an updated perspective on the mechanisms that lead to CIN and the key mutations that are acquired in this pathway.
引用
收藏
页码:2059 / 2072
页数:14
相关论文
共 132 条
[1]
ALBERTINI RJ, 1990, ANNU REV GENET, V24, P305
[2]
AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol [J].
Anand, S ;
Penrhyn-Lowe, S ;
Venkitaraman, AR .
CANCER CELL, 2003, 3 (01) :51-62
[3]
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study [J].
Andreyev, HJN ;
Norman, AR ;
Cunningham, D ;
Oates, J ;
Dix, BR ;
Iacopetta, BJ ;
Young, J ;
Walsh, T ;
Ward, R ;
Hawkins, N ;
Beranek, M ;
Jandik, P ;
Benamouzig, R ;
Jullian, E ;
Laurent-Puig, P ;
Olschwang, S ;
Muller, O ;
Hoffmann, I ;
Rabes, HM ;
Zietz, C ;
Troungos, C ;
Valavanis, C ;
Yuen, ST ;
Ho, JWC ;
Croke, CT ;
O'Donoghue, DP ;
Giaretti, W ;
Rapallo, A ;
Russo, A ;
Bazan, V ;
Tanaka, M ;
Omura, K ;
Azuma, T ;
Ohkusa, T ;
Fujimori, T ;
Ono, Y ;
Pauly, M ;
Faber, C ;
Glaesener, R ;
de Goeij, AFPM ;
Arends, JW ;
Andersen, SN ;
Lövig, T ;
Breivik, J ;
Gaudernack, G ;
Clausen, OPF ;
De Angelis, P ;
Meling, GI ;
Rognum, TO ;
Smith, R .
BRITISH JOURNAL OF CANCER, 2001, 85 (05) :692-696
[4]
Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study [J].
Andreyev, HJN ;
Norman, AR ;
Cunningham, D ;
Oates, JR ;
Clarke, PA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (09) :675-684
[5]
Chromosomal instability by β-catenin/TCF transcription in APC or β-catenin mutant cells [J].
Aoki, K. ;
Aoki, M. ;
Sugai, M. ;
Harada, N. ;
Miyoshi, H. ;
Tsukamoto, T. ;
Mizoshita, T. ;
Tatematsu, M. ;
Seno, H. ;
Chiba, T. ;
Oshima, M. ;
Hsieh, C-L ;
Taketo, M. M. .
ONCOGENE, 2007, 26 (24) :3511-3520
[6]
Celecoxib for the prevention of colorectal adenomatous polyps [J].
Arber, Nadir ;
Eagle, Craig J. ;
Spicak, Julius ;
Racz, Istvan ;
Dite, Petr ;
Hajer, Jan ;
Zavoral, Miroslav ;
Lechuga, Maria J. ;
Gerletti, Paola ;
Tang, Jie ;
Rosenstein, Rebecca B. ;
Macdonald, Katie ;
Bhadra, Pritha ;
Fowler, Robert ;
Wittes, Janet ;
Zauber, Ann G. ;
Solomon, Scott D. ;
Levin, Bernard .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :885-895
[7]
CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[8]
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].
Barbie, David A. ;
Tamayo, Pablo ;
Boehm, Jesse S. ;
Kim, So Young ;
Moody, Susan E. ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Meylan, Etienne ;
Scholl, Claudia ;
Froehling, Stefan ;
Chan, Edmond M. ;
Sos, Martin L. ;
Michel, Kathrin ;
Mermel, Craig ;
Silver, Serena J. ;
Weir, Barbara A. ;
Reiling, Jan H. ;
Sheng, Qing ;
Gupta, Piyush B. ;
Wadlow, Raymond C. ;
Le, Hanh ;
Hoersch, Sebastian ;
Wittner, Ben S. ;
Ramaswamy, Sridhar ;
Livingston, David M. ;
Sabatini, David M. ;
Meyerson, Matthew ;
Thomas, Roman K. ;
Lander, Eric S. ;
Mesirov, Jill P. ;
Root, David E. ;
Gilliland, D. Gary ;
Jacks, Tyler ;
Hahn, William C. .
NATURE, 2009, 462 (7269) :108-U122
[9]
Carcinogen-specific induction of genetic instability [J].
Bardelli, A ;
Cahill, CP ;
Lederer, G ;
Speicher, MR ;
Kinzler, KW ;
Vogelstein, B ;
Lengauer, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5770-5775
[10]
Cytogenetic comparisons of synchronous carcinomas and polyps in patients with colorectal cancer [J].
Bardi, G ;
Parada, LA ;
Bomme, L ;
Pandis, N ;
Willen, R ;
Johansson, B ;
Jeppsson, B ;
Beroukas, K ;
Heim, S ;
Mitelman, F .
BRITISH JOURNAL OF CANCER, 1997, 76 (06) :765-769